Home / United States / Arbutus Biopharma Corporation (ABUS)

Arbutus Biopharma Corporation (ABUS)

Short position disclosed on August 31, 2026.

18,916,119 shares sold short

9.56% of the shares reported to the SEC on August 10, 2026

? funds not named

4 disclosures on record

FINRA publishes, twice a month, the number of shares sold short in each company. Their share of the stock is computed here on the count the company reports to the SEC, and this market appears in no ranking shared with the others.

Evolution of the disclosed total

010M20M30M

Jul 28Aug 10Aug 23Sep 5Sep 18

Number of shares sold short. Hover or tap the curve to see which funds make it up.

Open positions

The funds disclosing a short position that is still open.
Fund	Twelve months	Shares sold short	Over the year	Since
Aggregated total		18,916,119 shares	-737,168 shares	August 31, 2026

Follow by RSS

Get the moves on Arbutus Biopharma Corporation (ABUS) by mail.

No account: one address, one link to confirm, one link to stop in every message.

History of disclosures

4 disclosures on record for this share.
Date	Fund	Shares sold short	End of publication
August 31, 2026	Aggregated total	18,916,119 shares	still open
August 14, 2026	Aggregated total	18,456,085 shares
July 31, 2026	Aggregated total	20,236,241 shares
July 15, 2026	Aggregated total	19,653,287 shares

Download 4 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in the United States

Lucas GC Limited Ordinary Shar (LGCL) 61.62%
Flash Sports & Media Holdings, (FLZH) 59.16%
BTC Digital Ltd. Ordinary Shar (BTCT) 47.02%
Wolfspeed, Inc. (WOLF) 46.50%
Karyopharm Therapeutics Inc. C (KPTI) 43.27%
Ondas Inc. Common Stock (ONDS) 39.71%
Capricor Therapeutics, Inc. Co (CAPR) 38.16%
Hertz Global Holdings, Inc Com (HTZ) 36.25%
TruGolf Holdings, Inc. Class A (TRUG) 36.10%
Serve Robotics Inc. Common Sto (SERV) 35.35%
Nexera Technologies Ltd Ordina (NEXR) 35.00%
LENZ Therapeutics, Inc. Common (LENZ) 34.61%

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Arbutus Biopharma Corporation (ABUS), source FINRA, data as at August 31, 2026, https://www.quivad.com/action/arbutus-biopharma-corporation-abus